Unknown PHASE3 INTERVENTIONAL 2-arm NCT01113125

Scars After Central Venous Catheters

Topical Treatment With Glucocorticoids to Prevent Hypertrophic Scars and Keloid Due to Central Venous Access in Children

Sponsor: Mette Møller Handrup

Conditions Hypertrophic Scars Keloids

Interventions Betamethason-17-valerate and fusidic acid Fusidic Acid

Updated 5 times since 2017 Last updated: Feb 11, 2014 Started: Mar 31, 2010 Primary completion: Aug 31, 2014 Completion: Jul 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01113125, this PHASE3 trial focuses on Hypertrophic Scars and Keloids and remains ongoing. Sponsored by Mette Møller Handrup, it has been updated 5 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Mar 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mette Møller Handrup

Data source: Aarhus University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Aarhus, Denmark